Stéphane Bancel, Getty
May 24, 2021 06:55 AM EDTUpdated 10:18 AM
Coronavirus

Covid-19 roundup: Mod­er­na inks fill-fin­ish pact with Sam­sung Bi­o­log­ics; So­ri­ot dis­cuss­es vac­cine woes, says shot 'has a fu­ture' — re­port

Max Gelman

Senior Editor

Josh Sullivan

As Mod­er­na has ramped up its man­u­fac­tur­ing ca­pa­bil­i­ties and looks to dis­trib­ute its vac­cine dos­es to coun­tries in dire need, the com­pa­ny has inked a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Bris­tol My­ers re­veals more job cuts in New Jer­sey

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

Min­neso­ta 340B rev­enue dri­ven by hos­pi­tals and high-priced drugs, first state re­port says

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

A service from the Financial Times